BR112015010194B1 - Análogo de insulina de cadeia única, sequência de ácido nucleico e uso do mesmo - Google Patents

Análogo de insulina de cadeia única, sequência de ácido nucleico e uso do mesmo Download PDF

Info

Publication number
BR112015010194B1
BR112015010194B1 BR112015010194-1A BR112015010194A BR112015010194B1 BR 112015010194 B1 BR112015010194 B1 BR 112015010194B1 BR 112015010194 A BR112015010194 A BR 112015010194A BR 112015010194 B1 BR112015010194 B1 BR 112015010194B1
Authority
BR
Brazil
Prior art keywords
insulin
gly
chain
arg
leu
Prior art date
Application number
BR112015010194-1A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112015010194A2 (pt
Inventor
Michael Weiss
Original Assignee
Case Western Reserve University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Case Western Reserve University filed Critical Case Western Reserve University
Publication of BR112015010194A2 publication Critical patent/BR112015010194A2/pt
Publication of BR112015010194B1 publication Critical patent/BR112015010194B1/pt

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
BR112015010194-1A 2012-11-05 2013-11-05 Análogo de insulina de cadeia única, sequência de ácido nucleico e uso do mesmo BR112015010194B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722350P 2012-11-05 2012-11-05
US61/722,350 2012-11-05
PCT/US2013/068585 WO2014071405A2 (en) 2012-11-05 2013-11-05 Long-acting single-chain insulin analogues

Publications (2)

Publication Number Publication Date
BR112015010194A2 BR112015010194A2 (pt) 2017-12-12
BR112015010194B1 true BR112015010194B1 (pt) 2022-03-22

Family

ID=50628271

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015010194-1A BR112015010194B1 (pt) 2012-11-05 2013-11-05 Análogo de insulina de cadeia única, sequência de ácido nucleico e uso do mesmo

Country Status (15)

Country Link
US (2) US9499600B2 (https=)
EP (1) EP2914620B1 (https=)
JP (1) JP6584953B2 (https=)
KR (1) KR102163936B1 (https=)
CN (2) CN112266414A (https=)
AU (1) AU2013337250B2 (https=)
BR (1) BR112015010194B1 (https=)
CA (1) CA2890719C (https=)
EA (1) EA201590882A1 (https=)
ES (1) ES2694418T3 (https=)
IL (1) IL238651B (https=)
MX (1) MX2015005662A (https=)
PH (1) PH12015500989A1 (https=)
SG (1) SG11201503522RA (https=)
WO (1) WO2014071405A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014015078A1 (en) * 2012-07-17 2014-01-23 Michael Weiss O-linked carbohydrate-modified insulin analogues
US9624287B2 (en) 2012-07-17 2017-04-18 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
WO2015106269A2 (en) 2014-01-13 2015-07-16 Thermalin Diabetes, Llc Rapid action insulin formulations and pharmaceutical delivery systems
CZ308383B6 (cs) * 2014-06-30 2020-07-15 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Derivát inzulinu s cyklickou strukturou v C-konci B-řetězce
AU2015328222B9 (en) * 2014-10-06 2020-12-24 Case Western Reserve University Biphasic single-chain insulin analogues
AR105616A1 (es) 2015-05-07 2017-10-25 Lilly Co Eli Proteínas de fusión
JP7203415B2 (ja) 2015-12-23 2023-01-13 ケース ウェスタン リザーブ ユニバーシティ ポリマー溶融物内の超安定型インスリン類似体のカプセル化
EP3883957A4 (en) * 2018-11-19 2022-08-17 Case Western Reserve University SINGLE-CHAIN INSULIN ANALOGS WITH POLYALANINE C-DOMAIN SUBSEGMENTS
SG11202106167XA (en) 2018-12-11 2021-07-29 Sanofi Sa Insulin conjugates
TWI844709B (zh) 2019-07-31 2024-06-11 美商美國禮來大藥廠 鬆弛素(relaxin)類似物及其使用方法
KR20220112817A (ko) * 2019-12-10 2022-08-11 사노피 설폰아미드 및 폴리펩티드의 콘주게이트를 형성하는 방법
EP4405384A1 (en) 2021-09-20 2024-07-31 Kyon Biotech AG Arginase-insulin fusion protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
EP1193272B1 (en) * 2000-10-02 2004-06-30 Yonsei University Single-chain insulin analogs
US20060217290A1 (en) * 2003-04-29 2006-09-28 Kohn Wayne D Insulin analogs having protracted time action
KR100508616B1 (ko) * 2003-06-20 2005-08-17 신항철 염기성 아미노산 첨가를 통한 활성이 증가된 단일사슬 인슐린 아날로그
CN1902226A (zh) * 2003-12-03 2007-01-24 诺和诺德公司 单链胰岛素
EP2074140B8 (en) * 2006-10-04 2015-10-28 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
RU2010147076A (ru) * 2008-04-22 2012-05-27 Кейз Вестерн Ризев Юнивесити (Us) Аналоги инсулина специфичные к изоформам
WO2011003820A1 (de) * 2009-07-06 2011-01-13 Sanofi-Aventis Deutschland Gmbh Hitze- und schüttelstabile insulinzubereitungen
PL2451437T3 (pl) * 2009-07-06 2017-05-31 Sanofi-Aventis Deutschland Gmbh Wodne preparaty insuliny zawierające metioninę
US8399407B2 (en) 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
JP2014533241A (ja) * 2011-10-27 2014-12-11 ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ 超濃縮速効型インスリン類似体製剤
CA2898730A1 (en) * 2012-01-20 2013-07-25 Case Western Reserve University Glutamic acid-stabilized insulin analogues
AU2013323669B2 (en) * 2012-09-26 2018-03-01 Indiana University Research And Technology Corporation Insulin analog dimers

Also Published As

Publication number Publication date
JP2016506366A (ja) 2016-03-03
IL238651B (en) 2020-03-31
AU2013337250B2 (en) 2017-06-22
US20150274803A1 (en) 2015-10-01
US9975940B2 (en) 2018-05-22
EA201590882A1 (ru) 2015-09-30
KR20150096387A (ko) 2015-08-24
BR112015010194A2 (pt) 2017-12-12
US20170137488A1 (en) 2017-05-18
CA2890719A1 (en) 2014-05-08
WO2014071405A2 (en) 2014-05-08
EP2914620B1 (en) 2018-08-08
EP2914620A2 (en) 2015-09-09
EP2914620A4 (en) 2016-05-25
JP6584953B2 (ja) 2019-10-02
CN105008395B (zh) 2020-12-29
CA2890719C (en) 2023-02-14
MX2015005662A (es) 2015-08-20
CN105008395A (zh) 2015-10-28
SG11201503522RA (en) 2015-06-29
CN112266414A (zh) 2021-01-26
WO2014071405A3 (en) 2014-08-21
ES2694418T3 (es) 2018-12-20
KR102163936B1 (ko) 2020-10-13
IL238651A0 (en) 2015-06-30
PH12015500989A1 (en) 2015-07-13
US9499600B2 (en) 2016-11-22

Similar Documents

Publication Publication Date Title
BR112015010194B1 (pt) Análogo de insulina de cadeia única, sequência de ácido nucleico e uso do mesmo
US11174303B2 (en) Single-chain insulin analogues stabilized by a fourth disulfide bridge
US11142560B2 (en) Biphasic single-chain insulin analogues
AU2013337250A1 (en) Long-acting single-chain insulin analogues
US20220002373A1 (en) Single-chain insulin analogues with poly-alanine c-domain sub-segments
US20220235111A1 (en) Variant Single-Chain Insulin Analogues
US9200053B2 (en) Insulin analogues containing penta-fluoro-Phenylalanine at position B24
TW201831504A (zh) 增強穩定性之速效胰島素類似物
KR20150110677A (ko) N 말단 절단된 인슐린 유사체
BR112021005366A2 (pt) análogo de insulina de cadeia simples, uso deste e método para reduzir o açúcar no sangue de um paciente
AU2013237740B2 (en) Insulin analogues containing penta-fluora-phenyalanine at position B24
HK40045373A (en) Long-acting single-chain insulin analogues
HK1238651A1 (en) Biphasic single-chain insulin analogues

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/11/2013, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 10A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2747 DE 29-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.